Harvard Bioscience Inc Cash Flow-to-Debt Ratio
Harvard Bioscience Inc cash flow-to-debt ratio. Harvard Bioscience Inc (HBIO) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of $323.00K could theoretically repay 0% of its total liabilities ($68.87 Million) in one year. Check Harvard Bioscience Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Harvard Bioscience Inc (1999–2025)
Cash flow-to-debt ratio of Harvard Bioscience Inc from 1999 to 2025. Historical debt coverage capacity for Harvard Bioscience Inc across 27 annual periods. Check how high is Harvard Bioscience Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Harvard Bioscience Inc Cash Flow-to-Debt Ratio by Year (1999–2025)
Harvard Bioscience Inc cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for Harvard Bioscience Inc. For the full cash flow conversion analysis, see Harvard Bioscience Inc (HBIO) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $6.73 Million | $66.34 Million | ▲ +345.9% |
| 2024 | 0.02x | $1.44 Million | $63.30 Million | ▼ -89.6% |
| 2023 | 0.22x | $14.03 Million | $64.29 Million | ▲ +1285.3% |
| 2022 | 0.02x | $1.15 Million | $73.14 Million | ▼ -1.5% |
| 2021 | 0.02x | $1.26 Million | $78.94 Million | ▼ -86.4% |
| 2020 | 0.12x | $9.33 Million | $79.57 Million | ▲ +21.2% |
| 2019 | 0.10x | $8.05 Million | $83.18 Million | ▲ +254.5% |
| 2018 | 0.03x | $2.34 Million | $85.89 Million | ▼ -26.5% |
| 2017 | 0.04x | $1.06 Million | $28.45 Million | ▼ -75.5% |
| 2016 | 0.15x | $5.38 Million | $35.57 Million | ▲ +814.9% |
| 2015 | 0.02x | $705.00K | $42.62 Million | ▼ -84.6% |
| 2014 | 0.11x | $4.35 Million | $40.45 Million | ▲ +8.6% |
| 2013 | 0.10x | $4.06 Million | $40.98 Million | ▼ -64.0% |
| 2012 | 0.28x | $8.06 Million | $29.27 Million | ▲ +35.1% |
| 2011 | 0.20x | $6.35 Million | $31.14 Million | ▼ -42.7% |
| 2010 | 0.36x | $12.29 Million | $34.55 Million | ▼ -31.1% |
| 2009 | 0.52x | $16.51 Million | $31.97 Million | ▼ -18.3% |
| 2008 | 0.63x | $9.20 Million | $14.55 Million | ▲ +29.6% |
| 2007 | 0.49x | $12.05 Million | $24.72 Million | ▲ +24.6% |
| 2006 | 0.39x | $8.36 Million | $21.34 Million | ▲ +78.0% |
| 2005 | 0.22x | $5.20 Million | $23.62 Million | ▼ -31.7% |
| 2004 | 0.32x | $11.44 Million | $35.52 Million | ▲ +369.2% |
| 2003 | 0.07x | $2.03 Million | $29.55 Million | ▲ +64.8% |
| 2002 | 0.04x | $799.46K | $19.20 Million | ▼ -84.2% |
| 2001 | 0.26x | $4.10 Million | $15.55 Million | ▼ -20.6% |
| 2000 | 0.33x | $2.15 Million | $6.47 Million | ▲ +43.0% |
| 1999 | 0.23x | $2.93 Million | $12.63 Million | — |